BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20384904)

  • 1. Variation in characteristics of islets of Langerhans in insulin-resistant, diabetic and non-diabetic-rat strains.
    Jones HB; Nugent D; Jenkins R
    Int J Exp Pathol; 2010 Jun; 91(3):288-301. PubMed ID: 20384904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative histopathological assessment of retardation of islets of langerhans degeneration in rosiglitazone-dosed obese ZDF rats using combined insulin and collagens (I and III) immunohistochemistry with automated image analysis and statistical modeling.
    Jones HB; Bigley AL; Pemberton J; Randall KJ
    Toxicol Pathol; 2013; 41(3):425-44. PubMed ID: 23047688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet beta cell failure in the 60% pancreatectomised obese hyperlipidaemic Zucker fatty rat: severe dysfunction with altered glycerolipid metabolism without steatosis or a falling beta cell mass.
    Delghingaro-Augusto V; Nolan CJ; Gupta D; Jetton TL; Latour MG; Peshavaria M; Madiraju SR; Joly E; Peyot ML; Prentki M; Leahy J
    Diabetologia; 2009 Jun; 52(6):1122-32. PubMed ID: 19294363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death.
    Finegood DT; McArthur MD; Kojwang D; Thomas MJ; Topp BG; Leonard T; Buckingham RE
    Diabetes; 2001 May; 50(5):1021-9. PubMed ID: 11334404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes.
    Hirose H; Lee YH; Inman LR; Nagasawa Y; Johnson JH; Unger RH
    J Biol Chem; 1996 Mar; 271(10):5633-7. PubMed ID: 8621426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in pancreatic islet glucokinase and hexokinase activities with increasing age, obesity, and the onset of diabetes.
    Cockburn BN; Ostrega DM; Sturis J; Kubstrup C; Polonsky KS; Bell GI
    Diabetes; 1997 Sep; 46(9):1434-9. PubMed ID: 9287043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat.
    Tokuyama Y; Sturis J; DePaoli AM; Takeda J; Stoffel M; Tang J; Sun X; Polonsky KS; Bell GI
    Diabetes; 1995 Dec; 44(12):1447-57. PubMed ID: 7589853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low mitochondrial glycerol phosphate dehydrogenase and pyruvate carboxylase in pancreatic islets of Zucker diabetic fatty rats.
    MacDonald MJ; Tang J; Polonsky KS
    Diabetes; 1996 Nov; 45(11):1626-30. PubMed ID: 8866570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat.
    Pick A; Clark J; Kubstrup C; Levisetti M; Pugh W; Bonner-Weir S; Polonsky KS
    Diabetes; 1998 Mar; 47(3):358-64. PubMed ID: 9519740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal insulin hypersecretion in insulin-resistant Zucker diabetic and Zucker fatty rats: role of enhanced fuel metabolism.
    Zhou YP; Cockburn BN; Pugh W; Polonsky KS
    Metabolism; 1999 Jul; 48(7):857-64. PubMed ID: 10421226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships.
    Lee Y; Hirose H; Ohneda M; Johnson JH; McGarry JD; Unger RH
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10878-82. PubMed ID: 7971976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats.
    Gowda N; Dandu A; Singh J; Biswas S; Raghav V; Lakshmi MN; Shilpa PC; Sunil V; Reddy A; Sadasivuni M; Aparna K; Verma MK; Moolemath Y; Anup MO; Venkataranganna MV; Somesh BP; Jagannath MR
    BMC Pharmacol Toxicol; 2013 May; 14():28. PubMed ID: 23692921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes.
    Shimabukuro M; Zhou YT; Levi M; Unger RH
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2498-502. PubMed ID: 9482914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of adipoinsular axis in prediabetic zucker diabetic fatty rats by diazoxide.
    Alemzadeh R; Tushaus KM
    Endocrinology; 2004 Dec; 145(12):5476-84. PubMed ID: 15319354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in islet capillary angioarchitecture coincide with impaired B-cell function but not with insulin resistance in male Otsuka-Long-Evans-Tokushima fatty rats: dimorphism of the diabetic phenotype at an advanced age.
    Mizuno A; Noma Y; Kuwajima M; Murakami T; Zhu M; Shima K
    Metabolism; 1999 Apr; 48(4):477-83. PubMed ID: 10206441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phlorizin treatment prevents the decrease in plasma insulin levels but not the progressive histopathological changes in the pancreatic islets during aging of Zucker diabetic fatty rats.
    Janssen SW; Martens GJ; Sweep CG; Span PN; Verhofstad AA; Hermus AR
    J Endocrinol Invest; 2003 Jun; 26(6):508-15. PubMed ID: 12952363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
    Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive histopathological changes in pancreatic islets of Zucker Diabetic Fatty rats.
    Janssen SW; Hermus AR; Lange WP; Knijnenburg Q; van der Laak JA; Sweep CG; Martens GJ; Verhofstad AA
    Exp Clin Endocrinol Diabetes; 2001; 109(5):273-82. PubMed ID: 11507651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM.
    Lee Y; Hirose H; Zhou YT; Esser V; McGarry JD; Unger RH
    Diabetes; 1997 Mar; 46(3):408-13. PubMed ID: 9032096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of islet size and islet size distribution resulting from protein-malnutrition in lean (Fa/Fa) and obese (fa/fa) Zucker rats.
    Tse EO; Gregoire FM; Reusens B; Remacle C; Hoet JJ; Johnson PR; Stern JS
    Obes Res; 1997 Nov; 5(6):563-71. PubMed ID: 9449141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.